57728-59-3 Usage
Description
(3-CHLORO-BENZOYLAMINO)-ACETIC ACID is an organic compound with the molecular structure featuring a chloro-benzoyl group and an amino group attached to an acetic acid backbone. It is characterized by its potential pharmaceutical and chemical applications due to its unique molecular structure and functional groups.
Uses
Used in Pharmaceutical Industry:
(3-CHLORO-BENZOYLAMINO)-ACETIC ACID is used as an intermediate compound for the synthesis of various pharmaceuticals, particularly those with anticonvulsant and cardiotonic properties. Its molecular structure allows for further chemical modifications to enhance its therapeutic effects and target specific medical conditions.
Used in Chemical Research:
In the field of chemical research, (3-CHLORO-BENZOYLAMINO)-ACETIC ACID serves as a valuable compound for studying the effects of chloro and amino substitutions on the chemical and biological properties of acetic acid derivatives. This can lead to the development of new compounds with improved characteristics and applications.
Used in Drug Metabolism Studies:
(3-CHLORO-BENZOYLAMINO)-ACETIC ACID, being a metabolite of certain drugs, is used in drug metabolism studies to understand the biotransformation processes in the body. This knowledge can be applied to optimize drug dosages, reduce side effects, and improve the overall efficacy of medications.
Check Digit Verification of cas no
The CAS Registry Mumber 57728-59-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,7,2 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 57728-59:
(7*5)+(6*7)+(5*7)+(4*2)+(3*8)+(2*5)+(1*9)=163
163 % 10 = 3
So 57728-59-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H8ClNO3/c10-7-3-1-2-6(4-7)9(14)11-5-8(12)13/h1-4H,5H2,(H,11,14)(H,12,13)/p-1
57728-59-3Relevant articles and documents
MAGL inhibitor as well as preparation method and application thereof
-
, (2021/03/30)
The invention relates to a compound shown as a formula I in the description and a pharmaceutically acceptable salt thereof, a preparation method, an intermediate for preparing the compound, a composition containing the compound or salt, and application of
Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabetics
-
Page/Page column 15, (2021/01/26)
Compounds for the treatment of hyperglycemia and/or diabetes are provided. The compounds, which inhibit the enzyme dipeptidyl peptidase (DPP-4), are based on the structure where n1=0-2 such as 0 or 1; R1 is i) a saturated or unsaturated, substituted or un
MAGL inhibitor and preparation method and application thereof
-
Paragraph 0011-0013, (2020/08/30)
The invention belongs to the field of medicines, and relates to a compound and a pharmaceutically acceptable salt thereof, a preparation method thereof, a composition containing the compound or the salt, and their use in the treatment of MAGL-mediated dis
